Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infectionsRani Burm(Ghent University), Philip Meuleman(Ghent University Hospital)GutAugust 17, 202210.1136/gutjnl-2022-327216Cited by 15SaveCiteExport RISWatch citationsRelated PapersVirus–Host Protein Interaction Network of the Hepatitis E Virus ORF2-4 by Mammalian Two-Hybrid Assays|Viruses|2023|3